Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Citi
Cipla
Mallinckrodt
Medtronic
Fish and Richardson
Cerilliant
Colorcon

Generated: July 19, 2018

DrugPatentWatch Database Preview

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of pseudoephedrine hydrochloride; triprolidine hydrochloride freedom to operate?

Pseudoephedrine hydrochloride; triprolidine hydrochloride
is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Fosun Pharma, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for pseudoephedrine hydrochloride; triprolidine hydrochloride.
Summary for PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
US Patents:0
Tradenames:12
Applicants:13
NDAs:16
Drug Master File Entries: 49
DailyMed Link:PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE at DailyMed

US Patents and Regulatory Information for PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma CORPHED pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088602-001 Apr 11, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cenci HISTAFED pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088283-001 Apr 20, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Newtron Pharms TRILITRON pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088515-001 Jan 9, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088318-002 Jan 13, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Queensland Health
Dow
Julphar
Teva
Mallinckrodt
Daiichi Sankyo
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.